Concepedia

Brittany Harvey

BH

Statistics

Publications

18

Citations

7.2K

H-Index

17

Active since

2016

Affiliations

University of North Carolina at Chapel Hill(Current)

University of South Florida

Alexion Pharmaceuticals (United States)

University of Miami

Yale University

Brittany Harvey is an author at University of North Carolina at Chapel Hill specializing in medicine, myasthenia gravis, and pharmacotherapy.

ORCID

Publications per year

2016–2025

18

Publications

18

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison et al. · Journal of Clinical Oncology · 2018 · 2.5K citations · Full text

, , +15

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison et al. · Archives of Pathology & Laboratory Medicine · 2018 · 1.5K citations · Full text

, , +15

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey et al. · Journal of Clinical Oncology · 2021 · 998 citations · Full text

, , +17

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline

Nadine Tung, Judy C. Boughey, Lori J. Pierce et al. · Journal of Clinical Oncology · 2020 · 324 citations · Full text

, , +17

1–5 of 18